Pulmonary embolism (PE) is one of the most serious complications in cancer patients. There are different treatment modalities for PE patients with very limited data available on outcomes among Patients. This analysis included from National Inpatient Sample between January 2016 and December 2020. We reported baseline characteristics hospital hospitalized modalities. identified 362,749 acute duri...

BACKGROUND Although stent implantation is used worldwide for peripheral arterial disease, there is little data on the safety and long-term patency of stents implanted for venous disease. METHODS AND RESULTS We studied 13 patients with 14 lesions (6 males, 7 females, mean age: 63.2±10.2 years) diagnosed with venous stenosis and who underwent venous stenting. We examined the location of the ste...

We have read through the case report article with great interest, entitled “Combined catheter thrombus fragmentation and percutaneous thrombectomy in a patient with massive pulmonary emboli and acute cerebral infarct,” by Uğurlu et al. (1) and published in Anatol J Cardiol 2015; 15: 69-74. For the last two years, ultrasound-assisted catheter-directed thrombolytic (USAT) has been used as an alte...

Patients with high-risk or intermediate-risk pulmonary embolism (PE) require more aggressive therapy, such as systemic thrombolysis. Although parenteral thrombolysis leads to faster clot resolution, it is associated a high risk for significant bleeding and its complications. The use of catheter-directed (CDT) decreases exposure thrombolytics reduces the complications mortality. Adding ultrasoun...

Abstract Objectives Direct intrahepatic portosystemic shunt (DIPS) stent placement is an effective treatment for patients with Budd-Chiari syndrome (BCS); however, thrombotic occlusion of DIPS remains a cause concern. The purpose this study to describe novel technique balloon-occluded-thrombolysis (BOT) occluded stent, and compare it the conventional catheter-directed-thrombolysis (CDT). Method...